MC2071A1 - Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant - Google Patents

Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant

Info

Publication number
MC2071A1
MC2071A1 MC892078A MC2078A MC2071A1 MC 2071 A1 MC2071 A1 MC 2071A1 MC 892078 A MC892078 A MC 892078A MC 2078 A MC2078 A MC 2078A MC 2071 A1 MC2071 A1 MC 2071A1
Authority
MC
Monaco
Prior art keywords
compound
formula
active ingredient
prop
pharmaceutically acceptable
Prior art date
Application number
MC892078A
Other languages
English (en)
French (fr)
Inventor
Rahim Saad
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC2071A1 publication Critical patent/MC2071A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC892078A 1988-11-23 1989-11-22 Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant MC2071A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827339A GB8827339D0 (en) 1988-11-23 1988-11-23 Antiviral compounds

Publications (1)

Publication Number Publication Date
MC2071A1 true MC2071A1 (fr) 1990-10-03

Family

ID=10647307

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892078A MC2071A1 (fr) 1988-11-23 1989-11-22 Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant

Country Status (25)

Country Link
EP (1) EP0375164B1 (de)
JP (1) JPH0753748B2 (de)
CN (1) CN1022570C (de)
AT (1) ATE104676T1 (de)
AU (1) AU620471B2 (de)
CA (1) CA2003607A1 (de)
DD (1) DD289534A5 (de)
DE (1) DE68914809T2 (de)
DK (1) DK586489A (de)
ES (1) ES2063147T3 (de)
FI (1) FI895572A7 (de)
GB (1) GB8827339D0 (de)
HU (1) HU204842B (de)
IE (1) IE893731L (de)
IL (1) IL92402A0 (de)
MC (1) MC2071A1 (de)
MY (1) MY104976A (de)
NO (1) NO171168C (de)
NZ (1) NZ231478A (de)
PH (1) PH26745A (de)
PL (1) PL162956B1 (de)
PT (1) PT92375B (de)
RU (1) RU1831486C (de)
YU (1) YU47096B (de)
ZA (1) ZA898926B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465297B1 (de) * 1990-07-04 1996-01-31 Merrell Dow Pharmaceuticals Inc. 9-Purinyl-Phosphonsäurederivate
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
GB9125271D0 (en) * 1991-11-27 1992-01-29 Wellcome Found Anti-hbv pyrimidine nucleoside
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
EP0346108A3 (de) * 1988-06-09 1991-04-24 The Wellcome Foundation Limited Anti-infektiöse Nukleoside

Also Published As

Publication number Publication date
CN1022570C (zh) 1993-10-27
GB8827339D0 (en) 1988-12-29
DK586489A (da) 1990-05-24
PT92375A (pt) 1990-05-31
AU4544289A (en) 1990-06-14
YU47096B (sh) 1994-12-28
DD289534A5 (de) 1991-05-02
FI895572A7 (fi) 1990-05-24
JPH0327394A (ja) 1991-02-05
NZ231478A (en) 1992-09-25
PT92375B (pt) 1995-07-18
NO894658L (no) 1990-05-25
EP0375164A1 (de) 1990-06-27
ATE104676T1 (de) 1994-05-15
IE893731L (en) 1990-05-23
DE68914809T2 (de) 1994-08-11
NO171168B (no) 1992-10-26
NO171168C (no) 1993-02-03
YU221289A (en) 1991-02-28
MY104976A (en) 1994-07-30
ZA898926B (en) 1991-07-31
AU620471B2 (en) 1992-02-20
PH26745A (en) 1992-09-28
PL162956B1 (pl) 1994-01-31
CA2003607A1 (en) 1990-05-23
HU204842B (en) 1992-02-28
FI895572A0 (fi) 1989-11-22
IL92402A0 (en) 1990-07-26
RU1831486C (ru) 1993-07-30
DK586489D0 (da) 1989-11-22
HU896136D0 (en) 1990-02-28
DE68914809D1 (de) 1994-05-26
NO894658D0 (no) 1989-11-22
JPH0753748B2 (ja) 1995-06-07
ES2063147T3 (es) 1995-01-01
CN1042916A (zh) 1990-06-13
HUT52110A (en) 1990-06-28
EP0375164B1 (de) 1994-04-20

Similar Documents

Publication Publication Date Title
MC1882A1 (fr) Composes anti-viraux
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
SK279767B6 (sk) Farmaceutická kombinácia na použitie pri ošetrovan
MC1551A1 (fr) Composes antiviraux
RU2114860C1 (ru) МОНО-, ДИ- ИЛИ ТРИСЛОЖНЫЕ ЭФИРЫ 2-АМИНО-6-(С1 - С5-АЛКОКСИ-9-(βD-АРАБИНОФУРАНОЗИЛ)-9Н-ПУРИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
KR100521292B1 (ko) 탄소환 뉴클레오시드 반황산염 및 그의 바이러스성 감염치료 용도
EP1095029B1 (de) Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus
JP2791116B2 (ja) 治療用化合物
MC2071A1 (fr) Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant
MC1914A1 (fr) Nucleosides therapeutiques
JPH04253914A (ja) 抗ｈｂｖピリミジンヌクレオシド
FR2534808A1 (fr) Composition antivirale contenant du 2-(4-chlorophenoxymethyl)-3,3-dimethyl-1-(1,2,4-triazole-1-yl)-2-butanol
JPH0560478B2 (de)
JPH07502741A (ja) 治療用ヌクレオシド
EP0072137A1 (de) Antivirale Deoxyuridin-Derivate
MC2216A1 (fr) Procede pour la preparation de composes antiviraux et de formulations pharmaceutiques les contenant
DE69629188T2 (de) Verwendung von (r)-penciclovirtriphosphat zur herstellung eines arzneimittels zur behandlung von viruserkrankungen
EP0095292A1 (de) 5-(2-Halovinyl)-2'-deoxyuridin-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Anwendung bei der Behandlung von viralen Infektionen
BE697967A (de)
MC1766A1 (fr) Procede pour la preparation de 3'-azido-nucleosides et procede pour preparer des formulations pharmaceutiques les contenant
FR2505823A1 (fr) Derives d'isoprenylamine et compositions pharmaceutiques renfermant ces derives

Legal Events

Date Code Title Description
YP Annual fee paid